EUVIMED · CrossrefJournal
The CRISPR Journal
ISSN 2573-1599 · SAGE Publications
Latest articles
Targeted Genetic Knockout of Can f 1, the Major Allergen in Dogs
Addressing the Blind Spots of Deaminase Base Editors with CRISPR-Cas Glycosylase-Based Editors
Comparison of CRISPR-Cas-Based Knockdown of Endogenous mRNA in Sensory Neurons
PARP1 Constrains Insertional Prime Editing in a Context-Dependent Manner
Hidden Outcomes of CRISPR-Cas9 Genome Editing Revealed by Targeted Sequencing in Isogenic Human iPSC Clones
AI and the CRISPR Ecosystem: A Mixed Bag
Telomere-Targeting CRISPR-Cas9 Induces Distinct DNA Damage Responses
Recombinant Fusion of Polyglutamic Acid Enhances Cell-Penetrating Peptide-Mediated CRISPR-Cas9 Delivery
Genomic Benchmarking Reveals Reduced and Context-Dependent Transferability of AI-Engineered Bxb1 Recombinases for Large-Fragment Genome Writing
Evaluation of Prime Editing Efficiency in Human Immortalized MSC-TERT Cells with Osteogenic Potential for Modeling FGFR2 -Linked Craniosynostosis
Development and Characterization of RNA Aptamer-Mediated Modular Base Editors Containing Staphylococcus aureus Cas9 Derivatives and Novel Deaminase Orthologs
An Optimized Workflow for In Vitro Transcription of Single Guide RNAs Minimizes Innate Immune Activation
The Diversifying Distribution Trends of Maturing CRISPR Technologies by Addgene
Safe Speeding on the Highway of Science
Advice from the CRISPR Whisperer
Optimization of Genome-Wide CRISPR Screens Using Dual-Guide RNA Infection with Cas9 Electroporation (DICE)
A Potent CRISPR-Cas12l Double-Strand Break Gene Editor
Increasing the Effective Gene Drive Homing Rate by Targeting the Haploinsufficient Spermatogenesis Gene Klhl10
Are We Making Genetically Modified Humans?
Induction of SpCas9-Directed Immune Responses Using Lipid Nanoparticles and Identification of SpCas9-Derived T Cell Epitopes in C57BL/6 Mice
Corrigendum to: “Subtypes of Type I-E CRISPR-Cas Systems Distribution in Human Escherichia coli Isolates from China”
CRISPR Learns to Read the Epigenome
Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa
CRISPR Medicine Needs Infrastructure, Not Just Innovation
Subtypes of Type I-E CRISPR-Cas Systems Distribution in Human Escherichia coli Isolates from China
Conditional Expression of Cas9 and dCas9 in Lucilia cuprina Reveals dCas9-Associated Lethality
Under Pressure: Can CRISPR Deliver Despite Contextual Headwinds?
A Streamlined CRISPRa Architecture with Dual Pol II/Pol III Promoter and Optimized scRNA Enables Robust and Tunable Gene Activation
Acknowledgment of Reviewers 2025
Regulatory Support for CRISPR in Ag: A Timely EU-Turn
EUVIMED